0001649325-15-000009.txt : 20150807 0001649325-15-000009.hdr.sgml : 20150807 20150807160341 ACCESSION NUMBER: 0001649325-15-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150806 FILED AS OF DATE: 20150807 DATE AS OF CHANGE: 20150807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NephroGenex, Inc. CENTRAL INDEX KEY: 0001338095 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3200 BEECHLEAF COURT STREET 2: SUITE 900 CITY: RALEIGH STATE: NC ZIP: 27604 BUSINESS PHONE: (609) 986-1780 MAIL ADDRESS: STREET 1: 3200 BEECHLEAF COURT STREET 2: SUITE 900 CITY: RALEIGH STATE: NC ZIP: 27604 FORMER COMPANY: FORMER CONFORMED NAME: NephroGenex Inc DATE OF NAME CHANGE: 20050907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Jaikrishna CENTRAL INDEX KEY: 0001649325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36303 FILM NUMBER: 151037300 MAIL ADDRESS: STREET 1: C/O NEPHROGENEX, INC. STREET 2: 3200 BEECHLEAF COURT, SUITE 900 CITY: RALEIGH STATE: NC ZIP: 27604 4 1 wf-form4_143897780812885.xml FORM 4 X0306 4 2015-08-06 0 0001338095 NephroGenex, Inc. NRX 0001649325 Patel Jaikrishna C/O NEPHROGENX, INC. 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 0 1 0 0 Chief Medical Officer Options to Purchase Common Stock 4.12 2015-08-06 4 A 0 54347 0 A 2016-08-06 2025-08-06 Common Stock 54347.0 54347 D 25% of the shares underlying the options will vest on April 30, 2016 and the remainder of the shares underlying the options will vest on a pro rata monthly basis for a three-year period following April 30, 2016. /s/ Pierre Legault as attorney-in-fact 2015-08-07